Historic AIM info – Deltex Medical Limited

The following information was reviewed and updated as at 22nd July 2024 and is being disclosed for the purposes of Rule 26 of the AIM Rule for Companies.

Where guidance is given to see another section of the website, please click on the highlighted word.

A description of the business:

See Business Description section.

The names of its directors and brief biographical details of each:

See Directors section.

Description of the responsibilities of the members of the board of directors and details of any committees of the board of directors and their responsibilities:

See Board Committees section.

Its country of incorporation and main country of operation:

Deltex Medical Group plc is incorporated in England and Wales (Registration Number 3902895) which is also its main country of operation. Deltex Medical Group plc is traded on the UK AIM market only.

Its current constitutional documents (e.g. its Articles of Association):

The number of AIM securities in issue (noting any held as treasury shares) and, insofar as it is aware, the percentage of AIM securities that is not in public hands together with the identity and percentage holdings of its significant shareholders.

Please see share information

Details of any restrictions on the transfer of its AIM securities:

Not applicable

UK City Code on Takeovers and Mergers:

The Company is subject to the provisions of the UK City Code on Takeovers and Mergers.

Corporate Governance:

Please click here for details on our Corporate Governance

Modern Slavery:

Modern slavery encompasses slavery, servitude, human trafficking and forced labour. Deltex Medical Limited has a zero tolerance approach to any form of modern slavery. We are committed to acting ethically and with integrity and transparency in all business dealings.

For copies of the annual and interim reports please see Annual & Interim Reports section.

For all notifications made in the past 12 months please see News Releases section.

For most recent admission document together with any circulars or similar publications sent to shareholders within the past 12 months:

Shareholder circulars: Please see News releases.
Initial IPO: view Preliminary prospectus.

General Enquiries

For general enquiries, notification of change of interest in shareholding under Disclosure and Transparency Rules, or if you are a shareholder, who wishes to have additional copies of the Report and Accounts, Interim Statements, presentations etc, please contact:

Natalie Wettler

Company Secretary
Deltex Medical Group plc
Terminus Road
Chichester
West Sussex
PO19 8TX

Tel: +44 (0)1243 523152
Fax: +44 (0)1243 532534
finance@deltexmedical.com

Administrative Enquiries

Queries concerning shareholdings in Deltex Medical Group plc, such as the loss of share certificate, dividend payments or change of address, should be directed, in the first instance, to the registrar:

Equiniti Limited

Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA

Tel: 0371 384 2030 (within the UK) or +44 (0) 121 415 7047 from overseas. Lines open 8:30am to 5:30pm (UK) time Monday to Friday (excluding UK public holidays in England and Wales). On line: help.shareview.co.uk (From here you will be able to email your query securely).

Shareholder enquiries

Corporate Governance

You can read our full Corporate Governance statement here.